CellaVision AB (publ) (OTCMKTS:CLVSF) Short Interest Down 21.2% in December

CellaVision AB (publ) (OTCMKTS:CLVSF) was the recipient of a large drop in short interest in December. As of December 15th, there was short interest totaling 11,278 shares, a drop of 21.2% from the November 30th total of 14,319 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is presently ∞ days. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is presently ∞ days.

CellaVision AB (publ) Price Performance

CLVSF stock opened at $16.83 on Tuesday. The business has a 50 day moving average of $17.51 and a 200-day moving average of $18.66. CellaVision AB has a 12-month low of $16.69 and a 12-month high of $16.83.

CellaVision AB (publ) Company Profile

CellaVision AB (publ), headquartered in Lund, Sweden, is a developer and manufacturer of advanced digital cell morphology solutions for clinical laboratories. The company’s systems automate the preparation, imaging and classification of blood and body fluid slides, enabling laboratory professionals to optimize workflow and improve diagnostic accuracy. CellaVision’s platform is designed to support a broad range of hematology analyses, including white blood cell differentiation, red blood cell morphology assessment and platelet evaluation.

The company’s core offering revolves around its digital microscopy instruments and proprietary software.